Detection of Novel Gene Biomarkers in non-small cell lung cancer using integrated approaches in DNA methylation expression-Reference-Cited by-同舟云学术

Detection of Novel Gene Biomarkers in non-small cell lung cancer using integrated approaches in DNA methylation expression

Published:2022-10-28 Issue: Volume: Page:
ISSN:
Container-title:Proceedings of the 2022 11th International Conference on Bioinformatics and Biomedical Science
language:
Short-container-title:

Author:

Pai Tun-Wen¹^ORCID

Affiliation:

1. National Taipei University of Technology, Taiwan

Publisher

ACM

Link

https://dl.acm.org/doi/pdf/10.1145/3571532.3571534

Reference54 articles.

1. Ferlay J. , Colombet M. , Soerjomataram I. , Mathers C. , Parkin D.M. , Piñeros M. , Znaor A. & Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer. 144 (8).1941–1953 . 2019 . Ferlay J., Colombet M., Soerjomataram I., Mathers C., Parkin D.M., Piñeros M., Znaor A. & Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer. 144 (8).1941–1953. 2019.

2. Gettinger S. Horn L. Jackman D. Spigel D. Antonia S. Hellmann M. Powderly J. Heist R. Sequist L.V. Smith D.C. Leming P. Geese W.J. Yoon D. Li A. Brahmer J. Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: results from the CA209-003 study. Journal of Clinical Oncology.36(17).1675–1684.2018. Gettinger S. Horn L. Jackman D. Spigel D. Antonia S. Hellmann M. Powderly J. Heist R. Sequist L.V. Smith D.C. Leming P. Geese W.J. Yoon D. Li A. Brahmer J. Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: results from the CA209-003 study. Journal of Clinical Oncology.36(17).1675–1684.2018.

3. Oken M.M. Hocking W.G. Kvale P.A. Andriole G.L. Buys S.S. Church T.R. Crawford E.D. Fouad M.N. Isaacs C. Reding D.J. Weissfeld J.L. Yokochi L.A. O'Brien B. Ragard L.R. Rathmell J.M. Riley T.L. Wright P. Caparaso N. Hu P. Izmirlian G. Pinsky P.F. Prorok P.C. Kramer B.S. Miller A.B. Gohagan J.K. Berg C.D. PLCO Project Team. Screening by chest radiograph and lung cancer mortality: The Prostate Lung Colorectal and Ovarian (PLCO) randomized trial. JAMA. 306 (17).1865–1873. 2011. Oken M.M. Hocking W.G. Kvale P.A. Andriole G.L. Buys S.S. Church T.R. Crawford E.D. Fouad M.N. Isaacs C. Reding D.J. Weissfeld J.L. Yokochi L.A. O'Brien B. Ragard L.R. Rathmell J.M. Riley T.L. Wright P. Caparaso N. Hu P. Izmirlian G. Pinsky P.F. Prorok P.C. Kramer B.S. Miller A.B. Gohagan J.K. Berg C.D. PLCO Project Team. Screening by chest radiograph and lung cancer mortality: The Prostate Lung Colorectal and Ovarian (PLCO) randomized trial. JAMA. 306 (17).1865–1873. 2011.

4. Aberle D.R. , Adams A.M. , Berg C.D. , Black W.C. , Clapp J.D. , Fagerstrom R.M. , Gareen I.F. , Gatsonis C. , Marcus P.M. , Sicks J.D. Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal Medicine. 365(5).395–409 . 2011 . Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., Gareen I.F., Gatsonis C., Marcus P.M., Sicks J.D. Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal Medicine. 365(5).395–409. 2011.

5. Huo J. Shen C. Volk R.J. and Shih Y.T. Use of CT and chest radiography for lung cancer screening before and after publication of screening guidelines: intended and unintended uptake. JAMA Intern. Med. 177(3).439–441.2017. Huo J. Shen C. Volk R.J. and Shih Y.T. Use of CT and chest radiography for lung cancer screening before and after publication of screening guidelines: intended and unintended uptake. JAMA Intern. Med. 177(3).439–441.2017.